T. Rowe Price Associates

T. Rowe Price Associates’s Nutex Health NUTX Stock Holding History

T. Rowe Price Associates’s Portfolio NUTX Stock Details NUTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$340K	Buy
2025 Q3	–	Sell
2025 Q2	$214K	Buy
2023 Q2	–	Sell
2023 Q1	$46K	Buy
2022 Q4	$84K	Buy